Intrinsic Value of S&P & Nasdaq Contact Us

Catalent, Inc. CTLT NYSE

NYSE • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
44/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$74.25
+17%

Catalent, Inc. (CTLT) — Analyst outlook / Analyst consensus target is. Based on 21 analyst ratings, the consensus is bullish — 8 Buy, 12 Hold, 1 Sell.

The consensus price target is $74.25 (low: $41.00, high: $132.00), representing an upside of 17% from the current price $63.48.

CTLT Stock — 12-Month Price Forecast

$74.25
▲ +16.97% Upside
Average Price Target
Based on 21 Wall Street analysts offering 12-month price targets for Catalent, Inc., the average price target is $74.25, with a high forecast of $132.00, and a low forecast of $41.00.
The average price target represents a +16.97% change from the last price of $63.48.
Highest Price Target
$132.00
Average Price Target
$74.25
Lowest Price Target
$41.00

CTLT Analyst Ratings

Hold
21
Ratings
8 Buy
12 Hold
1 Sell
Based on 21 analysts giving stock ratings to Catalent, Inc. in the past 3 months
Rating breakdown
Buy
8 38%
Hold
12 57%
Sell
1 5%
38%
Buy
8 analysts
57%
Hold
12 analysts
5%
Sell
1 analysts
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message